9-133209160-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014581.4(OBP2B):c.40G>A(p.Ala14Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000948 in 1,604,096 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014581.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OBP2B | ENST00000372034.8 | c.40G>A | p.Ala14Thr | missense_variant | 1/7 | 1 | NM_014581.4 | ENSP00000361104.3 | ||
OBP2B | ENST00000618116.4 | c.40G>A | p.Ala14Thr | missense_variant | 1/7 | 1 | ENSP00000484615.1 | |||
OBP2B | ENST00000461961.2 | n.82G>A | non_coding_transcript_exon_variant | 1/6 | 1 | |||||
OBP2B | ENST00000473737.5 | n.40G>A | non_coding_transcript_exon_variant | 1/8 | 1 | ENSP00000434927.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000706 AC: 14AN: 198184Hom.: 0 AF XY: 0.0000657 AC XY: 7AN XY: 106524
GnomAD4 exome AF: 0.0000978 AC: 142AN: 1451972Hom.: 0 Cov.: 32 AF XY: 0.0000956 AC XY: 69AN XY: 721468
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 15, 2024 | The c.40G>A (p.A14T) alteration is located in exon 1 (coding exon 1) of the OBP2B gene. This alteration results from a G to A substitution at nucleotide position 40, causing the alanine (A) at amino acid position 14 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at